Metagil-GM2

Composition: Glimepiride 2 mg + Metformin 500 mg (Sustained Release) Bilayered

Metagil GM2 combines Glimepiride 2 mg with Metformin SR 500 mg for stronger control of Type 2 Diabetes. This combination works by improving insulin response after meals and reducing overall glucose levels throughout the day. Metagil GM2 is commonly prescribed when lower-strength therapies are insufficient, and it helps maintain stable sugar levels with long-lasting action due to its sustained-release formulation.

Uses:

• Type 2 Diabetes requiring higher-dose therapy

• Reduction of fasting and post-meal blood glucose

• Improved HbA1c control

Side Effects:

• Low blood sugar

• Headache, dizziness

• Stomach discomfort

• Rare: lactic acidosis

Other Details:

• Should be taken with food

• Avoid alcohol to reduce risk of lactic acidosis

• Regular sugar monitoring is important